医薬品受託製造の世界市場、2024年～2028年

医薬品受託製造市場、2024年～2028年

医薬品受託製造市場は2023-2028年に648億米ドル、予測期間中のCAGRは8.1％で成長すると予測されます。当レポートでは、医薬品受託製造市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。特許切れやジェネリック医薬品需要の増加、コアコンピタンスへの注力ニーズの高まり、強力な研究資金などが市場を牽引しています。

本調査では、今後数年間の医薬品受託製造市場の成長を促進する主な要因の1つとして、米国FDA承認製造施設の増加を挙げています。また、生物学的療法に対する需要の高まりとビッグデータの出現は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第3章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• 医薬品受託製造の世界市場 2018-2022
• エンドユーザー別セグメント分析 2018-2022
• サービス別セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：エンドユーザー別

• 市場セグメンテーション
• 比較：エンドユーザー別
• 大規模製薬会社：市場規模と予測 2023-2028
• 中小規模製薬企業：市場規模と予測 2023-2028
• ジェネリック医薬品会社：市場規模と予測 2023-2028
• 市場機会：エンドユーザー別

第7章 市場セグメンテーション：サービス別

• 市場セグメンテーション
• 比較：サービス別
• API/原薬製造：市場規模と予測 2023-2028
• 最終剤形：市場規模と予測 2023-2028
• 二次包装：市場規模と予測 2023-2028
• 市場機会：サービス別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• インド：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場の機会・抑制要因

第11章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第12章 競合分析

• 企業プロファイル
• 企業の市場ポジショニング
• Almac Group Ltd.
• Boehringer Ingelheim International GmbH
• Cadila Pharmaceuticals Ltd.
• Charles River Laboratories International Inc.
• Cmic Holdings Co. Ltd
• Dr Reddys Laboratories Ltd.
• Laboratory Corp. of America Holdings
• Lonza Group Ltd.
• Lupin Ltd.
• OPTIMAPHARM d.o.o.
• Parexel International Corp.
• PCI Pharma Services
• Recipharm AB
• Syneos Health Inc.
• Thermo Fisher Scientific Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits6: Executive Summary - Chart on Market Segmentation by Service
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Company Market Positioning
• Exhibits10: Parent Market
• Exhibits11: Data Table on - Parent Market
• Exhibits12: Market characteristics analysis
• Exhibits13: Value Chain Analysis
• Exhibits14: Offerings of companies included in the market definition
• Exhibits15: Market segments
• Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits20: Historic Market Size - Data Table on Global Pharmaceutical Contract Manufacturing Market 2018 - 2022 ($ billion)
• Exhibits21: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
• Exhibits22: Historic Market Size - Service Segment 2018 - 2022 ($ billion)
• Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• Exhibits25: Five forces analysis - Comparison between 2023 and 2028
• Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits31: Chart on Market condition - Five forces 2023 and 2028
• Exhibits32: Chart on End-user - Market share 2023-2028 (%)
• Exhibits33: Data Table on End-user - Market share 2023-2028 (%)
• Exhibits34: Chart on Comparison by End-user
• Exhibits35: Data Table on Comparison by End-user
• Exhibits36: Chart on Big pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
• Exhibits37: Data Table on Big pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
• Exhibits38: Chart on Big pharmaceutical companies - Year-over-year growth 2023-2028 (%)
• Exhibits39: Data Table on Big pharmaceutical companies - Year-over-year growth 2023-2028 (%)
• Exhibits40: Chart on Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
• Exhibits41: Data Table on Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
• Exhibits42: Chart on Small and medium-sized pharmaceutical companies - Year-over-year growth 2023-2028 (%)
• Exhibits43: Data Table on Small and medium-sized pharmaceutical companies - Year-over-year growth 2023-2028 (%)
• Exhibits44: Chart on Generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
• Exhibits45: Data Table on Generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
• Exhibits46: Chart on Generic pharmaceutical companies - Year-over-year growth 2023-2028 (%)
• Exhibits47: Data Table on Generic pharmaceutical companies - Year-over-year growth 2023-2028 (%)
• Exhibits48: Market opportunity by End-user ($ billion)
• Exhibits49: Data Table on Market opportunity by End-user ($ billion)
• Exhibits50: Chart on Service - Market share 2023-2028 (%)
• Exhibits51: Data Table on Service - Market share 2023-2028 (%)
• Exhibits52: Chart on Comparison by Service
• Exhibits53: Data Table on Comparison by Service
• Exhibits54: Chart on API/bulk drug manufacturing - Market size and forecast 2023-2028 ($ billion)
• Exhibits55: Data Table on API/bulk drug manufacturing - Market size and forecast 2023-2028 ($ billion)
• Exhibits56: Chart on API/bulk drug manufacturing - Year-over-year growth 2023-2028 (%)
• Exhibits57: Data Table on API/bulk drug manufacturing - Year-over-year growth 2023-2028 (%)
• Exhibits58: Chart on Final dosage form - Market size and forecast 2023-2028 ($ billion)
• Exhibits59: Data Table on Final dosage form - Market size and forecast 2023-2028 ($ billion)
• Exhibits60: Chart on Final dosage form - Year-over-year growth 2023-2028 (%)
• Exhibits61: Data Table on Final dosage form - Year-over-year growth 2023-2028 (%)
• Exhibits62: Chart on Secondary packaging - Market size and forecast 2023-2028 ($ billion)
• Exhibits63: Data Table on Secondary packaging - Market size and forecast 2023-2028 ($ billion)
• Exhibits64: Chart on Secondary packaging - Year-over-year growth 2023-2028 (%)
• Exhibits65: Data Table on Secondary packaging - Year-over-year growth 2023-2028 (%)
• Exhibits66: Market opportunity by Service ($ billion)
• Exhibits67: Data Table on Market opportunity by Service ($ billion)
• Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits69: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits70: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits71: Chart on Geographic comparison
• Exhibits72: Data Table on Geographic comparison
• Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits77: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits78: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits79: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits80: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits97: Chart on India - Market size and forecast 2023-2028 ($ billion)
• Exhibits98: Data Table on India - Market size and forecast 2023-2028 ($ billion)
• Exhibits99: Chart on India - Year-over-year growth 2023-2028 (%)
• Exhibits100: Data Table on India - Year-over-year growth 2023-2028 (%)
• Exhibits101: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits102: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits103: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits104: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits105: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits106: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits107: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits108: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits109: Market opportunity By Geographical Landscape ($ billion)
• Exhibits110: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits111: Impact of drivers and challenges in 2023 and 2028
• Exhibits112: Overview on criticality of inputs and factors of differentiation
• Exhibits113: Overview on factors of disruption
• Exhibits114: Impact of key risks on business
• Exhibits115: Companies covered
• Exhibits116: Matrix on companies position and classification
• Exhibits117: Almac Group Ltd. - Overview
• Exhibits118: Almac Group Ltd. - Product / Service
• Exhibits119: Almac Group Ltd. - Key offerings
• Exhibits120: Boehringer Ingelheim International GmbH - Overview
• Exhibits121: Boehringer Ingelheim International GmbH - Product / Service
• Exhibits122: Boehringer Ingelheim International GmbH - Key news
• Exhibits123: Boehringer Ingelheim International GmbH - Key offerings
• Exhibits124: Cadila Pharmaceuticals Ltd. - Overview
• Exhibits125: Cadila Pharmaceuticals Ltd. - Product / Service
• Exhibits126: Cadila Pharmaceuticals Ltd. - Key offerings
• Exhibits127: Charles River Laboratories International Inc. - Overview
• Exhibits128: Charles River Laboratories International Inc. - Business segments
• Exhibits129: Charles River Laboratories International Inc. - Key offerings
• Exhibits130: Charles River Laboratories International Inc. - Segment focus
• Exhibits131: Cmic Holdings Co. Ltd - Overview
• Exhibits132: Cmic Holdings Co. Ltd - Business segments
• Exhibits133: Cmic Holdings Co. Ltd - Key offerings
• Exhibits134: Cmic Holdings Co. Ltd - Segment focus
• Exhibits135: Dr Reddys Laboratories Ltd. - Overview
• Exhibits136: Dr Reddys Laboratories Ltd. - Business segments
• Exhibits137: Dr Reddys Laboratories Ltd. - Key news
• Exhibits138: Dr Reddys Laboratories Ltd. - Key offerings
• Exhibits139: Dr Reddys Laboratories Ltd. - Segment focus
• Exhibits140: Laboratory Corp. of America Holdings - Overview
• Exhibits141: Laboratory Corp. of America Holdings - Business segments
• Exhibits142: Laboratory Corp. of America Holdings - Key news
• Exhibits143: Laboratory Corp. of America Holdings - Key offerings
• Exhibits144: Laboratory Corp. of America Holdings - Segment focus
• Exhibits145: Lonza Group Ltd. - Overview
• Exhibits146: Lonza Group Ltd. - Business segments
• Exhibits147: Lonza Group Ltd. - Key news
• Exhibits148: Lonza Group Ltd. - Key offerings
• Exhibits149: Lonza Group Ltd. - Segment focus
• Exhibits150: Lupin Ltd. - Overview
• Exhibits151: Lupin Ltd. - Business segments
• Exhibits152: Lupin Ltd. - Key news
• Exhibits153: Lupin Ltd. - Key offerings
• Exhibits154: Lupin Ltd. - Segment focus
• Exhibits155: OPTIMAPHARM d.o.o. - Overview
• Exhibits156: OPTIMAPHARM d.o.o. - Product / Service
• Exhibits157: OPTIMAPHARM d.o.o. - Key offerings
• Exhibits158: Parexel International Corp. - Overview
• Exhibits159: Parexel International Corp. - Product / Service
• Exhibits160: Parexel International Corp. - Key offerings
• Exhibits161: PCI Pharma Services - Overview
• Exhibits162: PCI Pharma Services - Product / Service
• Exhibits163: PCI Pharma Services - Key offerings
• Exhibits164: Recipharm AB - Overview
• Exhibits165: Recipharm AB - Business segments
• Exhibits166: Recipharm AB - Key offerings
• Exhibits167: Recipharm AB - Segment focus
• Exhibits168: Syneos Health Inc. - Overview
• Exhibits169: Syneos Health Inc. - Product / Service
• Exhibits170: Syneos Health Inc. - Key offerings
• Exhibits171: Thermo Fisher Scientific Inc. - Overview
• Exhibits172: Thermo Fisher Scientific Inc. - Business segments
• Exhibits173: Thermo Fisher Scientific Inc. - Key news
• Exhibits174: Thermo Fisher Scientific Inc. - Key offerings
• Exhibits175: Thermo Fisher Scientific Inc. - Segment focus
• Exhibits176: Inclusions checklist
• Exhibits177: Exclusions checklist
• Exhibits178: Currency conversion rates for US$
• Exhibits179: Research methodology
• Exhibits180: Information sources
• Exhibits181: Data validation
• Exhibits182: Validation techniques employed for market sizing
• Exhibits183: Data synthesis
• Exhibits184: 360 degree market analysis
• Exhibits185: List of abbreviations

Pharmaceutical Contract Manufacturing Market 2024-2028

The pharmaceutical contract manufacturing market is forecasted to grow by USD 64.8 bn during 2023-2028, accelerating at a CAGR of 8.1% during the forecast period. The report on the pharmaceutical contract manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by patent expiry and increasing demand for generic drugs, growing need to focus on core competencies, and strong research funding.

Technavio's pharmaceutical contract manufacturing market is segmented as below:

By End-user

• Big pharmaceutical companies
• Small and medium-sized pharmaceutical companies
• Generic pharmaceutical companies

By Service

• API/bulk drug manufacturing
• Final dosage form
• Secondary packaging

By Geographical Landscape

• North America
• Asia
• Europe
• Rest of World (ROW)

This study identifies the increasing number of US fda-approved manufacturing facilities as one of the prime reasons driving the pharmaceutical contract manufacturing market growth during the next few years. Also, rising demand for biological therapies and advent of big data will lead to sizable demand in the market.

The report on the pharmaceutical contract manufacturing market covers the following areas:

• Pharmaceutical contract manufacturing market sizing
• Pharmaceutical contract manufacturing market forecast
• Pharmaceutical contract manufacturing market industry analysis

The vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceutical contract manufacturing market vendors that include AbbVie Inc., Almac Group Ltd., Baxter International Inc., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Charles River Laboratories International Inc., Cmic Holdings Co. Ltd, Dalton Pharma Services, DR Reddys Laboratories Ltd., Grifols SA, Laboratory Corp. of America Holdings, Lonza Group Ltd., Lupin Ltd., Novotech Health Holdings, OPTIMAPHARM d.o.o., Parexel International Corp., PCI Pharma Services, Recipharm AB, Syneos Health Inc., and Thermo Fisher Scientific Inc.. Also, the pharmaceutical contract manufacturing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Service
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Pharmaceutical Contract Manufacturing Market 2018 - 2022
  • Historic Market Size - Data Table on Global Pharmaceutical Contract Manufacturing Market 2018 - 2022 ($ billion)
• 4.2 End-user segment analysis 2018 - 2022
  • Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
• 4.3 Service segment analysis 2018 - 2022
  • Historic Market Size - Service Segment 2018 - 2022 ($ billion)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

• 6.1 Market segments
  • Chart on End-user - Market share 2023-2028 (%)
  • Data Table on End-user - Market share 2023-2028 (%)
• 6.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
• 6.3 Big pharmaceutical companies - Market size and forecast 2023-2028
  • Chart on Big pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Big pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
  • Chart on Big pharmaceutical companies - Year-over-year growth 2023-2028 (%)
  • Data Table on Big pharmaceutical companies - Year-over-year growth 2023-2028 (%)
• 6.4 Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028
  • Chart on Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
  • Chart on Small and medium-sized pharmaceutical companies - Year-over-year growth 2023-2028 (%)
  • Data Table on Small and medium-sized pharmaceutical companies - Year-over-year growth 2023-2028 (%)
• 6.5 Generic pharmaceutical companies - Market size and forecast 2023-2028
  • Chart on Generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
  • Chart on Generic pharmaceutical companies - Year-over-year growth 2023-2028 (%)
  • Data Table on Generic pharmaceutical companies - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by End-user
  • Market opportunity by End-user ($ billion)
  • Data Table on Market opportunity by End-user ($ billion)

7 Market Segmentation by Service

• 7.1 Market segments
  • Chart on Service - Market share 2023-2028 (%)
  • Data Table on Service - Market share 2023-2028 (%)
• 7.2 Comparison by Service
  • Chart on Comparison by Service
  • Data Table on Comparison by Service
• 7.3 API/bulk drug manufacturing - Market size and forecast 2023-2028
  • Chart on API/bulk drug manufacturing - Market size and forecast 2023-2028 ($ billion)
  • Data Table on API/bulk drug manufacturing - Market size and forecast 2023-2028 ($ billion)
  • Chart on API/bulk drug manufacturing - Year-over-year growth 2023-2028 (%)
  • Data Table on API/bulk drug manufacturing - Year-over-year growth 2023-2028 (%)
• 7.4 Final dosage form - Market size and forecast 2023-2028
  • Chart on Final dosage form - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Final dosage form - Market size and forecast 2023-2028 ($ billion)
  • Chart on Final dosage form - Year-over-year growth 2023-2028 (%)
  • Data Table on Final dosage form - Year-over-year growth 2023-2028 (%)
• 7.5 Secondary packaging - Market size and forecast 2023-2028
  • Chart on Secondary packaging - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Secondary packaging - Market size and forecast 2023-2028 ($ billion)
  • Chart on Secondary packaging - Year-over-year growth 2023-2028 (%)
  • Data Table on Secondary packaging - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by Service
  • Market opportunity by Service ($ billion)
  • Data Table on Market opportunity by Service ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.5 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.9 India - Market size and forecast 2023-2028
  • Chart on India - Market size and forecast 2023-2028 ($ billion)
  • Data Table on India - Market size and forecast 2023-2028 ($ billion)
  • Chart on India - Year-over-year growth 2023-2028 (%)
  • Data Table on India - Year-over-year growth 2023-2028 (%)
• 9.10 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.11 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ billion)
  • Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 Almac Group Ltd.
  • Almac Group Ltd. - Overview
  • Almac Group Ltd. - Product / Service
  • Almac Group Ltd. - Key offerings
• 12.4 Boehringer Ingelheim International GmbH
  • Boehringer Ingelheim International GmbH - Overview
  • Boehringer Ingelheim International GmbH - Product / Service
  • Boehringer Ingelheim International GmbH - Key news
  • Boehringer Ingelheim International GmbH - Key offerings
• 12.5 Cadila Pharmaceuticals Ltd.
  • Cadila Pharmaceuticals Ltd. - Overview
  • Cadila Pharmaceuticals Ltd. - Product / Service
  • Cadila Pharmaceuticals Ltd. - Key offerings
• 12.6 Charles River Laboratories International Inc.
  • Charles River Laboratories International Inc. - Overview
  • Charles River Laboratories International Inc. - Business segments
  • Charles River Laboratories International Inc. - Key offerings
  • Charles River Laboratories International Inc. - Segment focus
• 12.7 Cmic Holdings Co. Ltd
  • Cmic Holdings Co. Ltd - Overview
  • Cmic Holdings Co. Ltd - Business segments
  • Cmic Holdings Co. Ltd - Key offerings
  • Cmic Holdings Co. Ltd - Segment focus
• 12.8 Dr Reddys Laboratories Ltd.
  • Dr Reddys Laboratories Ltd. - Overview
  • Dr Reddys Laboratories Ltd. - Business segments
  • Dr Reddys Laboratories Ltd. - Key news
  • Dr Reddys Laboratories Ltd. - Key offerings
  • Dr Reddys Laboratories Ltd. - Segment focus
• 12.9 Laboratory Corp. of America Holdings
  • Laboratory Corp. of America Holdings - Overview
  • Laboratory Corp. of America Holdings - Business segments
  • Laboratory Corp. of America Holdings - Key news
  • Laboratory Corp. of America Holdings - Key offerings
  • Laboratory Corp. of America Holdings - Segment focus
• 12.10 Lonza Group Ltd.
  • Lonza Group Ltd. - Overview
  • Lonza Group Ltd. - Business segments
  • Lonza Group Ltd. - Key news
  • Lonza Group Ltd. - Key offerings
  • Lonza Group Ltd. - Segment focus
• 12.11 Lupin Ltd.
  • Lupin Ltd. - Overview
  • Lupin Ltd. - Business segments
  • Lupin Ltd. - Key news
  • Lupin Ltd. - Key offerings
  • Lupin Ltd. - Segment focus
• 12.12 OPTIMAPHARM d.o.o.
  • OPTIMAPHARM d.o.o. - Overview
  • OPTIMAPHARM d.o.o. - Product / Service
  • OPTIMAPHARM d.o.o. - Key offerings
• 12.13 Parexel International Corp.
  • Parexel International Corp. - Overview
  • Parexel International Corp. - Product / Service
  • Parexel International Corp. - Key offerings
• 12.14 PCI Pharma Services
  • PCI Pharma Services - Overview
  • PCI Pharma Services - Product / Service
  • PCI Pharma Services - Key offerings
• 12.15 Recipharm AB
  • Recipharm AB - Overview
  • Recipharm AB - Business segments
  • Recipharm AB - Key offerings
  • Recipharm AB - Segment focus
• 12.16 Syneos Health Inc.
  • Syneos Health Inc. - Overview
  • Syneos Health Inc. - Product / Service
  • Syneos Health Inc. - Key offerings
• 12.17 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
• 13.9 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations